Page last updated: 2024-08-18

pyrroles and Hyperglycemia

pyrroles has been researched along with Hyperglycemia in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.57)18.7374
1990's3 (10.71)18.2507
2000's8 (28.57)29.6817
2010's15 (53.57)24.3611
2020's1 (3.57)2.80

Authors

AuthorsStudies
Gao, L; Li, R; Li, Y; Lu, W; Peng, M; Qiu, C; Shan, Y; Wang, X; Zheng, X1
Bako, HY; Ibrahim, MA; Ibrahim, S; Isah, MS1
Bai, X; Chi, Z; Cui, C; Dai, J; Ding, L; Guo, J; Kong, Y; Li, S; Lian, B; Mao, L; Sheng, X; Si, L; Tang, B; Wang, X; Yan, X; Zhou, L1
Ambrose, H; Bando, H; Banerji, U; Barrett, JC; Baselga, J; Bedard, PL; Berger, MF; Bouvier, N; Chandarlapaty, S; Chang, MT; Dean, EJ; Donoghue, MTA; Dougherty, B; El-Khoueiry, AB; Erinjeri, JP; Foxley, A; Hyman, DM; Lindemann, JPO; McEwen, R; Mita, A; Pass, M; Pérez-Fidalgo, JA; Reichel, JB; Schellens, JHM; Schiavon, G; Selcuklu, SD; Smyth, LM; Solit, DB; Soumerai, TE; Taylor, BS; Torrisi, J; Westin, SN1
He, M; Pan, H; Pu, M; Xiao, C1
Arch, RH; Atkinson, MA; Bluestone, JA; Brekken, RA; Calderon, B; Kabre, B; Kubeck, S; Lang, J; Pullen, N; Szot, GL; Villalta, SA; Wasserfall, C1
Ahn, CW; Cha, BS; Cho, Y; Choe, EY; Huh, KH; Kang, ES; Kim, MS; Kim, YS; Kwon, O; Lee, HC; Wang, HJ1
Du, Y; Gao, J; Hu, R; Lu, M; Wang, Y; Wei, W; Zhang, S; Zhou, Q; Zhu, H; Zuo, L1
Abdelaziz, DH; Ali, SA; Fathallah, SS; Mohamed, MS1
Grabowski, T; Grześkowiak, E; Karbownik, A; Lewandowska, M; Matuszewski, M; Połom, W; Sobańska, K; Szałek, E; Wolc, A1
Canas, JA; Caulfield, MP; Damaso, LC; Gidding, SS; Hossain, J; Mauras, N; Ross, JL; Sikes, KM; Taboada, MV1
Chatzopoulou, M; Demopoulos, V; Kubala, L; Lojek, A; Nicolaou, I; Papezikova, I; Pekarova, M1
Chen, IJ; Hsieh, SL; Kwan, AL; Lin, HL; Shen, KP; Wu, BN1
Boyle, A; Connelly, KA; Gilbert, RE; Kelly, D; Kompa, A; Krum, H; Martin, JH; Zhang, Y1
Chae, JK; Choi, JY; Hong, TJ; Jeong, MH; Kim, DS; Kim, KY; Kim, YJ; Kim, YN; Oh, SK; Park, JS; Seong, IW1
Iwai, K; Kitoh, M; Maruta, K; Nagamine, J; Nagata, R; Taiji, M; Tsuchida, A; Ushiroda, K1
Barter, PJ; Boekholdt, SM; Breazna, A; Kastelein, JJ; Rye, KA; Tardif, JC; Waters, DD1
El-Moselhy, MA; Heeba, GH; Mourad, AA; Taye, A1
Devaraj, S; Jialal, I; Venugopal, SK; Yang, T1
Daimon, M; Hirata, A; Igarashi, M; Kameda, W; Kato, T; Ohnuma, H; Oizumi, T; Saitoh, T; Sugiyama, K; Yamaguchi, H1
Li, L; Renier, G; Sawamura, T1
Hager, P; Hagman, B; Strömmer, L; Wikström, AC1
Fushimi, H1
Assaloni, R; Ceriello, A; Da Ros, R; Esposito, K; Giugliano, D; Maier, A; Piconi, L; Quagliaro, L1
Angel, I; Grosset, A; Langer, SZ; Perrault, G; Schoemaker, H1
Colafranceschi, C; Guinebault, P; McAnena-Morice, D; Rouchouse, A1
Angel, I; Langer, SZ1
Fujimori, S; Hirata, Y; Okada, K; Segawa, M1

Reviews

1 review(s) available for pyrroles and Hyperglycemia

ArticleYear
[Treatment of cerebral infarction patients with IGT].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 2

    Topics: Antidepressive Agents; Antipyrine; Atorvastatin; Cerebral Infarction; Edaravone; Free Radical Scavengers; Glucose Intolerance; Heptanoic Acids; Humans; Hyperglycemia; Hypertension; Hypertriglyceridemia; Insulin Resistance; Pyrroles; Secondary Prevention; Thrombolytic Therapy

2005

Trials

5 trial(s) available for pyrroles and Hyperglycemia

ArticleYear
Phase 1 trial of vorolanib (CM082) in combination with everolimus in patients with advanced clear-cell renal cell carcinoma.
    EBioMedicine, 2020, Volume: 55

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Disease Progression; Drug Administration Schedule; Everolimus; Female; Humans; Hypercholesterolemia; Hyperglycemia; Indoles; Kidney Neoplasms; Leukopenia; Male; Middle Aged; Protein Kinase Inhibitors; Proteinuria; Pyrroles; Pyrrolidines; Survival Analysis

2020
A randomized, double blind, placebo-controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated low-density lipoprotein cholesterol (LDL-C) and type 1 diabetes.
    Pediatric diabetes, 2015, Volume: 16, Issue:2

    Topics: Adolescent; Atorvastatin; Child; Cholesterol, LDL; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diet, Diabetic; Diet, Fat-Restricted; Double-Blind Method; Drug Monitoring; Exercise; Female; Glycated Hemoglobin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Pilot Projects; Pyrroles

2015
Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia.
    The Korean journal of internal medicine, 2010, Volume: 25, Issue:1

    Topics: Atorvastatin; Blood Glucose; Cholesterol, LDL; Female; Fluorobenzenes; Glycated Hemoglobin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperglycemia; Insulin; Male; Metabolic Syndrome; Middle Aged; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome

2010
Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial.
    Circulation, 2011, Aug-02, Volume: 124, Issue:5

    Topics: Aged; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Glycated Hemoglobin; Heptanoic Acids; Homeostasis; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Prospective Studies; Pyrroles; Quinolines

2011
Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients.
    Circulation, 2005, May-17, Volume: 111, Issue:19

    Topics: Anticholesteremic Agents; Atorvastatin; Biphenyl Compounds; Case-Control Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hyperglycemia; Hypertriglyceridemia; Inflammation; Irbesartan; Male; Middle Aged; Oxidative Stress; Postprandial Period; Pyrroles; Tetrazoles; Treatment Outcome

2005

Other Studies

22 other study(ies) available for pyrroles and Hyperglycemia

ArticleYear
Cathelicidin-related antimicrobial peptide protects against cardiac fibrosis in diabetic mice heart by regulating endothelial-mesenchymal transition.
    International journal of biological sciences, 2019, Volume: 15, Issue:11

    Topics: AMP-Activated Protein Kinases; Animals; Antimicrobial Cationic Peptides; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Echocardiography; Endothelial Cells; Endothelium; Epithelial-Mesenchymal Transition; Fibrosis; Glucose; Hemodynamics; Hyperglycemia; Male; Mice; Mice, Inbred C57BL; Pyrazoles; Pyrroles; Signal Transduction; Transforming Growth Factor beta

2019
Inhibition of JAK-STAT and NF-κB signalling systems could be a novel therapeutic target against insulin resistance and type 2 diabetes.
    Life sciences, 2019, Dec-15, Volume: 239

    Topics: Animals; Aspirin; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Interleukin-6; Janus Kinases; Male; NF-kappa B; Piperidines; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Serum Amyloid A Protein; Signal Transduction; STAT Transcription Factors; Tumor Necrosis Factor-alpha

2019
AKT Inhibition in Solid Tumors With AKT1 Mutations.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Jul-10, Volume: 35, Issue:20

    Topics: Adult; Aged; Alleles; Antineoplastic Agents; Biomarkers, Tumor; Diarrhea; Disease-Free Survival; DNA, Neoplasm; Drug Eruptions; Exanthema; Female; Humans; Hyperglycemia; Loss of Heterozygosity; Male; Middle Aged; Mutation; Neoplasms; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Response Evaluation Criteria in Solid Tumors; Signal Transduction

2017
Roles for redox signaling by NADPH oxidase in hyperglycemia-induced heme oxygenase-1 expression in the diabetic retina.
    Investigative ophthalmology & visual science, 2013, Jun-12, Volume: 54, Issue:6

    Topics: Acetophenones; Animals; Antioxidant Response Elements; Blotting, Western; Diabetic Retinopathy; Fluorescent Antibody Technique, Indirect; Glucose; Heme Oxygenase-1; Hyperglycemia; Imidazoles; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Organ Culture Techniques; Oxidation-Reduction; Oxidative Stress; Pyrroles; Reactive Oxygen Species; Retina; Signal Transduction

2013
Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function.
    Diabetes, 2013, Volume: 62, Issue:8

    Topics: Animals; Diabetes Mellitus, Type 1; Female; Humans; Hyperglycemia; Indoles; Inflammation; Islets of Langerhans; Mice; Mice, Inbred NOD; Pancreas; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Vascular Endothelial Growth Factor Receptor-2

2013
HMG CoA reductase inhibitor treatment induces dysglycemia in renal allograft recipients.
    Transplantation, 2014, Feb-27, Volume: 97, Issue:4

    Topics: Adult; Anticholesteremic Agents; Atorvastatin; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Dyslipidemias; Fasting; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Glomerular Filtration Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Immunosuppressive Agents; Incidence; Indoles; Kidney Transplantation; Male; Middle Aged; Pyrroles; Renal Insufficiency

2014
Atorvastatin inhibits hyperglycemia-induced expression of osteopontin in the diabetic rat kidney via the p38 MAPK pathway.
    Molecular biology reports, 2014, Volume: 41, Issue:4

    Topics: Animals; Atorvastatin; Blood Glucose; Body Weight; Diabetic Nephropathies; Gene Expression Regulation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Kidney Glomerulus; Kidney Tubules; Lipids; Male; MAP Kinase Signaling System; Osteopontin; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyrroles; Rats

2014
Synthesis and evaluation of novel pyrroles and pyrrolopyrimidines as anti-hyperglycemic agents.
    BioMed research international, 2014, Volume: 2014

    Topics: Animals; Diabetes Mellitus, Experimental; Drug Design; Hyperglycemia; Hypoglycemic Agents; Magnetic Resonance Spectroscopy; Male; Models, Chemical; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Structure-Activity Relationship; Sucrose; Sulfonylurea Compounds; Temperature

2014
The pharmacokinetics and hypoglycaemic effect of sunitinib in the diabetic rabbits.
    Pharmacological reports : PR, 2014, Volume: 66, Issue:5

    Topics: Administration, Oral; Animals; Area Under Curve; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Hyperglycemia; Hypoglycemic Agents; Indoles; Male; Protein Kinase Inhibitors; Pyrroles; Rabbits; Sunitinib

2014
The effect of aldose reductase inhibition by JMC-2004 on hyperglycemia-induced endothelial dysfunction.
    Neuro endocrinology letters, 2008, Volume: 29, Issue:5

    Topics: Aldehyde Reductase; Animals; Blotting, Western; Calcimycin; Cattle; Cell Line; Electrochemistry; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Glucose; Glyceraldehyde; Hydroxyl Radical; Hyperglycemia; Luminescence; Nitric Oxide; Nitric Oxide Synthase Type III; Peroxides; Phenols; Pyrroles

2008
Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
    The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:4

    Topics: Adipose Tissue; Animals; Atorvastatin; Blood Glucose; Body Weight; Brain; Dietary Fats; Female; Glutathione Peroxidase; Heptanoic Acids; Hyperglycemia; Hyperlipidemias; Insulin; Ketanserin; Lipid Peroxidation; Lipogenesis; Liver; Malondialdehyde; Mice; Mice, Inbred C57BL; Piperazines; PPAR gamma; Prazosin; Propranolol; Pyrroles; Superoxide Dismutase; Weight Gain

2009
Effect of atorvastatin on cardiac remodelling and mortality in rats following hyperglycemia and myocardial infarction.
    International journal of cardiology, 2010, Sep-03, Volume: 143, Issue:3

    Topics: Animals; Atorvastatin; Body Weight; Cardiac Volume; Collagen Type I; Collagen Type III; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Fibrosis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Myocardial Infarction; Myocardium; Pyrroles; Rats; Rats, Sprague-Dawley; Ventricular Remodeling

2010
Development of a new class of benzoylpyrrole-based PPARα/γ activators.
    Bioorganic & medicinal chemistry letters, 2011, Jan-01, Volume: 21, Issue:1

    Topics: Acetates; Animals; Carboxylic Acids; Hyperglycemia; Hypoglycemic Agents; Male; Mice; Mice, Obese; Obesity; PPAR alpha; PPAR gamma; Pyrroles; Rats; Structure-Activity Relationship

2011
Comparative study between atorvastatin and losartan on high fat diet-induced type 2 diabetes mellitus in rats.
    Fundamental & clinical pharmacology, 2013, Volume: 27, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atorvastatin; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet, High-Fat; Drug Therapy, Combination; Heptanoic Acids; Hypercholesterolemia; Hyperglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Losartan; Male; Obesity; Pioglitazone; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Tumor Necrosis Factor-alpha

2013
Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha.
    Diabetes, 2002, Volume: 51, Issue:10

    Topics: Acetophenones; alpha-Tocopherol; Antioxidants; Biphenyl Compounds; Cell Line; Ellagic Acid; Enzyme Activation; Enzyme Inhibitors; Humans; Hyperglycemia; Isoenzymes; Mesylates; Monocytes; NADPH Oxidases; Oligodeoxyribonucleotides, Antisense; Onium Compounds; Phosphoproteins; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Pyrroles; Superoxides

2002
Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes.
    Endocrine journal, 2003, Volume: 50, Issue:1

    Topics: Acrolein; Adult; Arginine; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Lysine; Male; Middle Aged; Norleucine; Pyrroles; Smoking

2003
Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation.
    Circulation research, 2004, Apr-16, Volume: 94, Issue:7

    Topics: Acetylcysteine; Adult; Aged; Anti-Infective Agents; Antioxidants; Arteriosclerosis; Cells, Cultured; Curcumin; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Flavonoids; Foam Cells; Gene Expression Regulation; Glucose; Glycation End Products, Advanced; Humans; Hyperglycemia; Macrophages; Male; MAP Kinase Signaling System; Mesylates; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NF-kappa B; Nitriles; Phosphorylation; Protein Kinase C; Protein Kinase C beta; Protein Processing, Post-Translational; Pyrroles; Receptors, LDL; RNA, Messenger; Signal Transduction; Sulfones; Transcription Factor AP-1; Tumor Necrosis Factor-alpha

2004
CRF-receptor 1 blockade attenuates acute posttraumatic hyperglycemia in rats.
    The Journal of surgical research, 2004, Jun-01, Volume: 119, Issue:1

    Topics: Acute Disease; Adrenocorticotropic Hormone; Animals; Biological Transport; Blood Glucose; Corticosterone; Dexamethasone; Glucocorticoids; Glucose; Hyperglycemia; Insulin; Male; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Wounds and Injuries

2004
In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonist.
    European journal of pharmacology, 1993, Apr-06, Volume: 234, Issue:2-3

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Glucose; Blood Pressure; Brimonidine Tartrate; Clonidine; Decerebrate State; Dioxanes; Epinephrine; Heart Rate; Hyperglycemia; Idazoxan; Indoles; Male; Mice; Motor Activity; Norepinephrine; Peripheral Nerves; Prazosin; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Stereoisomerism; Vasoconstriction

1993
Plasma determination of the enantiomers of SL 84.0418, a new antihyperglycaemic drug, by HPLC on a chiral alpha 1-AGP column.
    Chirality, 1992, Volume: 4, Issue:2

    Topics: Adrenergic alpha-Antagonists; Chromatography, High Pressure Liquid; Drug Stability; Humans; Hyperglycemia; Indoles; Orosomucoid; Pyrroles; Reproducibility of Results; Stereoisomerism

1992
Pre- and postsynaptic alpha-2 adrenoceptors as target for drug discovery.
    Journal of neural transmission. Supplementum, 1991, Volume: 34

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Azepines; Dioxanes; Dogs; Hyperglycemia; Hypoglycemic Agents; Hypothalamus; Idazoxan; In Vitro Techniques; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Norepinephrine; Pyrroles; Rats; Receptors, Adrenergic, alpha; Synapses

1991
The development of electroretinogram abnormalities and the possible role of polyol pathway activity in diabetic hyperglycemia and galactosemia.
    Metabolism: clinical and experimental, 1988, Volume: 37, Issue:5

    Topics: Animals; Cataract; Diabetes Mellitus, Experimental; Electroretinography; Galactitol; Galactosemias; Hyperglycemia; Inositol; Insulin; Male; Oxazines; Pyrroles; Rats; Rats, Inbred Strains; Retina; Sorbitol; Sugar Alcohols

1988